Literature DB >> 5020987

Autoregulation of thyroxine secretion into bile.

A P Hillier.   

Abstract

1. An investigation has been made into the effect on thyroxine secretion into bile of suddenly raising the thyroxine concentration in the liver.2. Isolated rat livers, perfused with Tyrode solution, were injected with trace amounts of radioactive thyroxine. This injected hormone was captured by the binding sites in the tissue and then gradually secreted into the bile. A second injection of 100 mug stable (non-radioactive) thyroxine caused an enormous increase in the secretion rate. At its peak, the concentration of thyroxine in the bile was about 24 x its concentration in the liver (this was 10 x higher than the concentration ratio at tracer thyroxine levels). The effect extended well into the physiological range and injections of only 0.1 mug stable thyroxine caused a transient doubling of the secretion rate. Tri-iodothyronine also accelerated thyroxine secretion but it was 30 x less potent than thyroxine.3. In contrast, the secretion of tri-iodothyronine into bile was only very slightly affected by injections of stable thyroxine or tri-iodothyronine, the maximum response being a 20-30% increase in the secretion rate.4. This autoregulating mechanism would help to stabilize the concentration of thyroxine in the tissues but not the concentration of tri-iodothyronine.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5020987      PMCID: PMC1331344          DOI: 10.1113/jphysiol.1972.sp009762

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  2 in total

1.  Some differences in the metabolism of thyroxine and triiodothyronine in the rat.

Authors:  N F MACLAGAN; J H WILKINSON
Journal:  J Physiol       Date:  1954-08-27       Impact factor: 5.182

2.  Active secretion of thyroxine into bile: the role of tissue thyroxine-binding sites.

Authors:  A P Hillier
Journal:  J Physiol       Date:  1972-03       Impact factor: 5.182

  2 in total
  5 in total

1.  Low doses of cholestyramine in the treatment of hyperthyroidism.

Authors:  Mahmoud Ali Kaykhaei; Mesbah Shams; Abdosamad Sadegholvad; Mohammad Hossein Dabbaghmanesh; Gholamhossein Ranjbar Omrani
Journal:  Endocrine       Date:  2008-10-23       Impact factor: 3.633

2.  Role of colestipol in the treatment of hyperthyroidism.

Authors:  P Hagag; H Nissenbaum; M Weiss
Journal:  J Endocrinol Invest       Date:  1998-12       Impact factor: 4.256

3.  Active secretion of thyroxine into bile: the role of tissue thyroxine-binding sites.

Authors:  A P Hillier
Journal:  J Physiol       Date:  1972-03       Impact factor: 5.182

4.  Deiodination of thyroid hormones by the perfused rat liver.

Authors:  A P Hillier
Journal:  J Physiol       Date:  1972-04       Impact factor: 5.182

5.  Clinical Trial of Four Weeks of Combination Therapy with Low-dose Methimazole and a Cholesterol Absorption Inhibitor as the Initial Treatment for Childhood-onset Graves' Disease.

Authors:  Satoshi Takakuwa; Yoko Kina
Journal:  Clin Pediatr Endocrinol       Date:  2014-02-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.